Ivantis

Medical Devices & EquipmentSeries CIrvine, USivantisinc.com

Latest round

Series C

Last raised

Jan 2017

Total raised

$132M

Investors

12

About Ivantis

Ivantis, Inc.Founded in 2007 and headquartered in Irvine, US, Ivantis, Inc. focuses on developing advanced ophthalmic devices., enabling it to expand its market reach. The CEO is Dave Van Meter, who has an extensive background in the medical device sector.Ivantis, Inc. primarily offers the Hydrus® Microstent, a minimally invasive glaucoma surgery device designed to improve intraocular pressure management in patients with mild to moderate primary open-angle glaucoma. This device creates outflow pathways for aqueous fluid, bypassing the trabecular meshwork to restore natural drainage.Ivantis, Inc. generates revenue through direct sales of its ophthalmic devices and surgical products to healthcare providers and institutions. Its revenue model is B2B, involving partnerships and distribution agreements with hospitals and clinics that perform glaucoma surgeries.The recent acquisition by Alcon Labs, Inc. in January 2022 will facilitate the international launch of the Hydrus Microstent, with plans for ongoing evidence-based research to support product development. The company is expected to focus on expanding into new markets, particularly in Europe and Asia, to reach a broader patient demographic by leveraging its enhanced capabilities post-acquisition.

Who invested in Ivantis

12 investors across 9 rounds

See all investors in Ivantis

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series C

    Jan 6, 2017

    Amount

    $25M

    Investors

    Locked

  2. Series B

    Sep 23, 2014

    Amount

    $25M

    Investors

    Locked

  3. Series B

    Jan 13, 2014

    Amount

    $14M

    Investors

    Locked

  4. Series B

    Aug 20, 2013

    Amount

    $5M

    Investors

    Locked

  5. Series B

    Feb 8, 2013

    Amount

    $27M

    Investors

    Locked

  6. Series A

    Apr 26, 2011

    Amount

    $17M

    Investors

    Locked

  7. Series A

    Jul 14, 2008

    Amount

    $4.5M

    Investors

    Locked

  8. Series A

    May 12, 2008

    Amount

    $15M

    Investors

    Locked

  9. Seed

    Jun 1, 2007

    Amount

    Undisclosed

    Investors

    Locked

Questions about Ivantis

Who invested in Ivantis?

Ivantis has 12 investors on record across 9 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Ivantis raised?

Ivantis has raised 9 venture rounds. Sign up free to see how much each round raised and the total.

When did Ivantis last raise money?

Ivantis's most recent round on record is a Series C, in Jan 2017.

What does Ivantis do?

Ivantis is a medical devices & equipment company.

Where is Ivantis headquartered?

Ivantis is headquartered in Irvine, US.

Which VCs invest in companies like Ivantis?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at Ivantis's stage. Their profiles are linked below.

Raising like Ivantis? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.